Success Story: Neuroscience Researcher Secures NIW Approval for Work Advancing Treatments for Neurological Disease
On July 31st, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a PhD Candidate & Graduate Teaching Assistant in the Field of Neuroscience (Approval Notice).
General Field: Neuroscience
Position at the Time of Case Filing: PhD Candidate & Graduate Teaching Assistant
Country of Origin: Nigeria
State of Residence at the Time of Filing: Alabama
Approval Notice Date: July 31st, 2026
Processing Time: 21 months, 30 days (Premium Processing Upgrade Requested)
Case Summary:
Developing safer and more effective treatments for neurological disorders requires researchers to look beyond symptoms and examine the biological processes that contribute to disease. This challenge formed the foundation of an I-140 EB-2 National Interest Waiver (NIW) case we prepared for a neuroscience researcher whose work focuses on understanding mechanisms involved in neurological disease and identifying potential avenues for improved therapies.
The client holds a master's degree and is currently conducting neuroscience research at a U.S. university. To protect the client’s privacy, we generalized the highly specialized details of the proposed endeavor. Broadly, the client plans to continue investigating how biological and environmental factors contribute to neurodegeneration, with the goal of identifying promising therapeutic targets and supporting the development of safer and more effective treatments for Parkinson’s disease.
In presenting the national importance of this endeavor, we connected the client’s research to the broader need for improved approaches to neurological disease. We explained that Parkinson’s disease affects a substantial U.S. population and imposes significant health and economic burdens. Because existing treatments primarily manage symptoms and can carry meaningful side effects, research that improves knowledge of disease mechanisms and helps identify new therapeutic targets has implications extending beyond an individual laboratory or employer.
The client had also established a strong record of research activity. At the time of filing, the client had authored 8 peer-reviewed journal articles, including 3 first-authored articles, 1 conference article, and 1 first-authored conference abstract. These publications had accumulated 183 citations, and the client had completed at least 4 peer reviews. Rather than presenting these numbers as sufficient by themselves, we demonstrated how they reflected independent recognition. Researchers had relied on the client’s findings and methods to inform their own studies, while several of the client’s papers ranked among the more highly cited neuroscience publications from their respective publication years. The client’s invitations to evaluate other researchers’ work further supported recognition of the client’s scientific expertise.
The case was additionally supported by 2 recommendation letters from experts familiar with the significance of the client’s work. Their perspectives helped connect the client’s prior accomplishments with the ability to continue making valuable contributions in neuroscience. One expert noted:
“Overall, [Client’s] research in the neuroscience field is of utmost importance to both the United States' and global research communities.”
By combining the client’s specialized education, publication record, independent citation evidence, peer-review activity, expert support, and continuing research plans, we demonstrated a sustained trajectory of contribution rather than relying on any single metric. This evidence helped establish that the client was well positioned to continue research with broader implications for neurological health and therapeutic development. We are pleased that the client’s I-140 NIW petition was approved and wish the client continued success in advancing this important area of research.